SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Focused Visit (Care-plan review) — Bob Marley — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientBob Marley
Date of birth1945-02-06
IdentifiersMRN HR-ML027-SYN-TD; SSN (made up) 000-27-4065
Document date1977-10-19
AuthorDesmond Clarke, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Melanoma review about three and a half months after surgery. [S]

History of Present Illness

Mr. Marley returns for his first melanoma surveillance visit, about three and a half months after digit-sparing excision of a stage IA acral melanoma of the right great toe. The graft is fully healed, and he runs and plays football without pain; he still wears the ankle support for football since the sprain eight weeks ago, which has healed. He has examined his skin and nails each month with a mirror and photographed the graft; he has seen no change. His HIV, hepatitis B, and hepatitis C tests from the preventive visit were negative, with no immunity to hepatitis B, and he is due the second hepatitis B vaccine. He leaves on tour next week. He has had no thoughts of self-harm. [S]

ElementDetail
GraftHealed; no change on his monthly photographs
ActivityRunning and football without pain
Self-examinationMonthly, including the soles and nails
ResultsHIV, hepatitis B surface antigen, and hepatitis C antibody negative; not immune to hepatitis B
PlansTouring from next week

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo weight loss, fever, or night sweats
RespiratoryNegativeNo cough
NeurologicalNegativeNo headache
IntegumentaryNegativeNo new bands, spots, or sores
Hematologic and lymphaticNegativeNo lumps in the groin or behind the knee
MusculoskeletalNegativeAnkle and toe pain-free

6 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for pain after surgery, no more than 3 g a dayTwo tablets every 6 hours as neededOral route1977-07-01 to 1977-07-10completedS
Ibuprofen 400 mg oral tablet, one tablet by mouth three times daily with food for up to 5 daysOne tablet three times daily with food for up to 5 daysOral route1977-08-24 to 1977-08-28completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1977-10-19Body height170cmS
1977-10-19Body weight66.4kgS
1977-10-19Body mass index (BMI) [Ratio]23kg/m2S
1977-10-19Systolic blood pressure118mm[Hg]S
1977-10-19Diastolic blood pressure74mm[Hg]S
1977-10-19Heart rate60/minS
1977-10-19Respiratory rate14/minS
1977-10-19Body temperature36.6CelS
1977-10-19Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1977-10-19Pain severity - 0-10 verbal numeric rating [Score] - Reported0{score}S
1977-10-19Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S

Physical Exam

Vital signs recorded on 1977-10-19; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 118/74, pulse 60; weight 66.4 kg
Right great toeGraft fully healed, smooth and adherent, with no pigment, nodule, or ulcer at the graft or its edges
Lymph nodesNo popliteal or inguinal nodes on either side; no axillary or cervical nodes
Skin and nailsFull skin examination including the scalp, palms, soles, between the toes, and all nails: no suspicious lesion
Right ankleNo swelling; stable; full range

Problems

ProblemClinical statusVerificationCodeProvenance
A brown-black band in the right great toenail, about 5 mm wide (about a third of the nail), with irregular dark lines, first noticed about two months ago after a knock at football and not growing out with the nail; the pigment extends onto the skin of the proximal nail fold (Hutchinson sign). Suspected subungual melanoma; dermoscopy and a full-thickness nail matrix biopsy booked this weekresolvedconfirmed L60.8S — Synthetic presenting problem linked to his documented toe lesion; superseded by the diagnosis at the surgical oncology consultation.
Acral lentiginous melanoma of the nail unit (subungual) of the right great toe, on full-thickness nail matrix biopsy: Breslow thickness 0.8 mm, not ulcerated, mitotic rate 1 per mm2, no lymphovascular or perineural invasion; clinical stage IB (cT1b N0 M0); synthetic modern detail linked to his documented acral lentiginous melanomaactiveconfirmed C43.71S — Synthetic thickness and stage; the site, the subtype, and the year are documented (D).
Lateral sprain of the right ankle (anterior talofibular ligament) from an inversion injury at football; Ottawa ankle rules negative, so no X-ray; resolvedresolvedconfirmed S93.401AS — Synthetic acute injury; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationFull skin and nail examination, including the scalp, palms, soles, between the toes, and all nailsAt diagnosis, then at each surveillance visitCompleted todayNo suspicious lesion
ExaminationGraft and scarEach surveillance visitCompleted todayHealed; no pigment or nodule
ExaminationExamination of the lymph node basins (right popliteal and inguinal) and the scarAt diagnosis, then at each surveillance visitCompleted todayNo nodes
ImagingImaging (CT, PET, or ultrasound) and LDHNot routine for stage I to II without symptomsNot indicatedStage IA without symptoms
Self-managementSkin self-examinationMonthly, taught after diagnosis and reviewed each visitCompleted todayDone monthly with graft photographs; technique reviewed
ReferralDermatology full skin examinationYearlyDueBooked for the spring
SurveyPain scoreEach visit after surgeryCompleted todayNo pain
SurveyDepression screen (PHQ-2)At each phase of careCompleted todayPHQ-2 score 0

Goal progress:

Immunizations given today: Hepatitis B vaccine (HepB-CpG), dose 2 of 2 [S]

Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Melanoma: Cutaneous, Version 3.2026 (2026); Swetter SM, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol 2019;80(1):208-250 (2019); Chouquet L, et al. Reconstruction After Wide Excision of the Nail Apparatus in the Treatment of Melanoma: A Systematic Literature Review. J Clin Med 2025;14(17):5932 (2025); Depression and Suicide Risk in Adults: Screening (2023); Adult Immunization Schedule by Age (2026)

Follow-up: Second hepatitis B vaccine dose given today, completing the series. Melanoma review in six months, or sooner for any new change. Dermatology in the spring. [S]